Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Application is based on Phase 2b/3 SELECTION study data with patients with moderately to severely…
Freecash introduces a zero-investment way to earn money by watching movies
Taxinexo Advances Large-Scale Commercial Deployment of Level 4 Autonomous Vehicles Across the United States
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering
Authority Engine Launches AI Ads Engine, Delivering 37% Click-Through Rates and $0.06 Cost Per Action Through Autonomous Campaign Optimization